Kingfa Science Q1 FY27 Results (NSE: KINGFA)
Signal: Growth reaccelerated
The read
The operating trajectory strengthened materially: revenue reached ₹688.57 Cr, up 49.1% YoY and 19.03% QoQ, while EBITDA rose 88.7% YoY to ₹116.16 Cr and EBITDA margin was 16.9%; PAT doubled to ₹80.21 Cr, but the 80.1% EPS growth lagging 101.6% PAT growth warrants monitoring for dilution or minority-interest effects.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹688.57 Cr | 49.1% | +19.03% |
| EBIT | ₹108.23 Cr | 95.9% | |
| Net profit | ₹80.21 Cr | 101.6% | |
| EPS | ₹59.19 | 80.1% | |
| EBIT margin | 16.9% |
P&L walk
Standalone revenue increased 49.1% YoY and 19.03% QoQ to ₹688.57 Cr, while EBITDA grew 88.7% YoY to ₹116.16 Cr and EBITDA margin reached 16.9%; PAT rose 101.6% YoY to ₹80.21 Cr, supported primarily by operating profit rather than other income.
Key positives
- Revenue of ₹688.57 Cr grew 49.1% YoY and 19.03% QoQ, materially ahead of the 22.1% YoY increase in Indian auto production, indicating growth beyond merely reported industry expansion.
- EBITDA grew 88.7% YoY to ₹116.16 Cr versus revenue growth of 49.1%, a 39.6 percentage-point growth gap, while EBITDA margin reached 16.9%.
- Domestic sales increased to ₹63,493.30 lakh from ₹42,512.28 lakh, and export sales rose to ₹5,364.12 lakh from ₹3,681.15 lakh, showing broad-based top-line growth.
Key concerns
- EPS rose 80.1% YoY to ₹59.19, materially below 101.6% PAT growth to ₹80.21 Cr; the cause of the divergence is not disclosed.
- Domestic revenue remained 92% of total revenue, leaving the business primarily exposed to Indian demand and domestic customer concentration.
- The filing does not disclose fixed-cost details, depreciation, capex, working-capital metrics or cash flow, limiting confirmation of the quality and durability of the margin expansion.
Research and educational content only. Not investment advice.